Manifold Bio: Funding, Investors & Team (Sep 2026)
Complex Bio is a biotechnology organization that includes a stage that empowers multiplexed quantitation of protein remedial plans, creating extraordinary information all through the medication improvement cycle to open estimation driven plan. The organization is building a protein barcoding stage to carry the force of multiplexed estimation to the improvement of protein therapeutics. It was established in 2020 and settled in Boston, Massachusetts.
Manifold Bio has raised $46.4M across 3 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Oct 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Manifold Bio Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Manifold Bio Funding Rounds
Manifold Bio raised $5.4M in an undisclosed round announced in Sep 2020.
1.8 years later, a Series A of $40.0M was announced in Jun 2022.
3.3 years later, an undisclosed round of $1.0M was announced in Oct 2025.
Manifold Bio Founders and Leadership Team
Contact details for the Manifold Bio team: 3 of 3 have an email address on file.
Start 14-day free trial →Manifold Bio Funding Compared to Other Biotechnology Startups
Manifold Bio's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Manifold Bio in Biotechnology and Boston
Companies Similar to Manifold Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Manifold Bio Funding FAQs
What does Manifold Bio do?
Complex Bio is a biotechnology organization that includes a stage that empowers multiplexed quantitation of protein remedial plans, creating extraordinary information all through the medication improvement cycle to open estimation driven plan. The organization is building a protein barcoding stage to carry the force of multiplexed estimation to the improvement of protein therapeutics. It was established in 2020 and settled in Boston, Massachusetts.
How much funding has Manifold Bio raised?
Manifold Bio has raised $46.4M across 3 rounds on record. The most recent is an undisclosed round of $1.0M announced in Oct 2025.
When did Manifold Bio last raise funding?
Manifold Bio's most recent funding round on record is an undisclosed round of $1.0M, announced in Oct 2025.
Who founded Manifold Bio?
FundedIQ lists Pierce Ogden (Founder), Shane Lofgren (Founder) at Manifold Bio.
Who is the CEO of Manifold Bio?
Gleb Kuznetsov is listed as CEO at Manifold Bio.
Where is Manifold Bio headquartered?
Manifold Bio is based in Boston, Massachusetts, United States.
How many employees does Manifold Bio have?
Manifold Bio is in the 11-50 employee band.
How does Manifold Bio's funding compare to other Biotechnology startups?
Manifold Bio's latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Manifold Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Manifold Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.